Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
DVAX vs SIGA
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
DVAX vs SIGA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.82B | $337M |
| Revenue (TTM) | $331M | $95M |
| Net Income (TTM) | $-43M | $23M |
| Gross Margin | 83.2% | 68.6% |
| Operating Margin | 3.2% | 25.1% |
| Forward P/E | 31.6x | 2.8x |
| Total Debt | $254M | $795K |
| Cash & Equiv. | $96M | $154.97T |
DVAX vs SIGA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Feb 26 | Return |
|---|---|---|---|
| Dynavax Technologie… (DVAX) | 100 | 253.3 | +153.3% |
| SIGA Technologies, … (SIGA) | 100 | 111.9 | +11.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DVAX vs SIGA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DVAX is the clearest fit if your priority is income & stability and growth exposure.
- beta 0.75
- Rev growth 19.4%, EPS growth 5.0%, 3Y rev CAGR -14.2%
- Lower volatility, beta 0.75, Low D/E 42.6%, current ratio 10.80x
SIGA carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.2% 10Y total return vs DVAX's 10.0%
- Lower P/E (2.8x vs 31.6x)
- 24.6% margin vs DVAX's -13.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.4% revenue growth vs SIGA's -31.8% | |
| Value | Lower P/E (2.8x vs 31.6x) | |
| Quality / Margins | 24.6% margin vs DVAX's -13.1% | |
| Stability / Safety | Beta 0.75 vs SIGA's 1.15 | |
| Dividends | 12.8% yield; 4-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +41.9% vs SIGA's +0.6% | |
| Efficiency (ROA) | 0.0% ROA vs DVAX's -4.6%, ROIC 0.0% vs -0.4% |
DVAX vs SIGA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DVAX vs SIGA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — DVAX and SIGA each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DVAX is the larger business by revenue, generating $331M annually — 3.5x SIGA's $95M. SIGA is the more profitable business, keeping 24.6% of every revenue dollar as net income compared to DVAX's -13.1%. On growth, DVAX holds the edge at +17.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $331M | $95M |
| EBITDAEarnings before interest/tax | $19M | $24M |
| Net IncomeAfter-tax profit | -$43M | $23M |
| Free Cash FlowCash after capex | $81M | $49M |
| Gross MarginGross profit ÷ Revenue | +83.2% | +68.6% |
| Operating MarginEBIT ÷ Revenue | +3.2% | +25.1% |
| Net MarginNet income ÷ Revenue | -13.1% | +24.6% |
| FCF MarginFCF ÷ Revenue | +24.4% | +51.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +17.7% | -95.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +90.9% | -111.8% |
Valuation Metrics
SIGA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 14.2x trailing earnings, SIGA trades at a 82% valuation discount to DVAX's 77.5x P/E.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.8B | $337M |
| Enterprise ValueMkt cap + debt − cash | $2.0B | -$154.97T |
| Trailing P/EPrice ÷ TTM EPS | 77.50x | 14.24x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.59x | 2.76x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 503.23x | -6387033.21x |
| Price / SalesMarket cap ÷ Revenue | 6.56x | 3.56x |
| Price / BookPrice ÷ Book value/share | 3.46x | 0.00x |
| Price / FCFMarket cap ÷ FCF | 30.24x | 6.91x |
Profitability & Efficiency
SIGA leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
SIGA delivers a 0.0% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-8 for DVAX. SIGA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to DVAX's 0.43x. On the Piotroski fundamental quality scale (0–9), DVAX scores 6/9 vs SIGA's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -8.1% | 0.0% |
| ROA (TTM)Return on assets | -4.6% | 0.0% |
| ROICReturn on invested capital | -0.4% | +0.0% |
| ROCEReturn on capital employed | -0.4% | 0.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.43x | 0.00x |
| Net DebtTotal debt minus cash | $159M | -$154.97T |
| Cash & Equiv.Liquid assets | $96M | $154.97T |
| Total DebtShort + long-term debt | $254M | $795,169 |
| Interest CoverageEBIT ÷ Interest expense | -5.28x | — |
Total Returns (Dividends Reinvested)
DVAX leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DVAX five years ago would be worth $17,455 today (with dividends reinvested), compared to $10,096 for SIGA. Over the past 12 months, DVAX leads with a +41.9% total return vs SIGA's +0.6%. The 3-year compound annual growth rate (CAGR) favors DVAX at 12.4% vs SIGA's 6.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +0.8% | -15.5% |
| 1-Year ReturnPast 12 months | +41.9% | +0.6% |
| 3-Year ReturnCumulative with dividends | +42.1% | +21.7% |
| 5-Year ReturnCumulative with dividends | +74.5% | +1.0% |
| 10-Year ReturnCumulative with dividends | +10.0% | +722.2% |
| CAGR (3Y)Annualised 3-year return | +12.4% | +6.8% |
Risk & Volatility
DVAX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DVAX is the less volatile stock with a 0.75 beta — it tends to amplify market swings less than SIGA's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DVAX currently trades 98.5% from its 52-week high vs SIGA's 48.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 1.15x |
| 52-Week HighHighest price in past year | $15.73 | $9.62 |
| 52-Week LowLowest price in past year | $9.20 | $4.29 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +48.9% |
| RSI (14)Momentum oscillator 0–100 | 75.7 | 44.0 |
| Avg Volume (50D)Average daily shares traded | 5.7M | 683K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates DVAX as "Buy" and SIGA as "Buy". SIGA is the only dividend payer here at 12.81% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $27.00 | — |
| # AnalystsCovering analysts | 11 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +12.8% |
| Dividend StreakConsecutive years of raises | — | 4 |
| Dividend / ShareAnnual DPS | — | $0.60 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.5% | 0.0% |
SIGA leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). DVAX leads in 2 (Total Returns, Risk & Volatility). 1 tied.
DVAX vs SIGA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is DVAX or SIGA a better buy right now?
For growth investors, Dynavax Technologies Corporation (DVAX) is the stronger pick with 19.
4% revenue growth year-over-year, versus -31. 8% for SIGA Technologies, Inc. (SIGA). SIGA Technologies, Inc. (SIGA) offers the better valuation at 14. 2x trailing P/E (2. 8x forward), making it the more compelling value choice. Analysts rate Dynavax Technologies Corporation (DVAX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DVAX or SIGA?
On trailing P/E, SIGA Technologies, Inc.
(SIGA) is the cheapest at 14. 2x versus Dynavax Technologies Corporation at 77. 5x. On forward P/E, SIGA Technologies, Inc. is actually cheaper at 2. 8x.
03Which is the better long-term investment — DVAX or SIGA?
Over the past 5 years, Dynavax Technologies Corporation (DVAX) delivered a total return of +74.
5%, compared to +1. 0% for SIGA Technologies, Inc. (SIGA). Over 10 years, the gap is even starker: SIGA returned +722. 2% versus DVAX's +10. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DVAX or SIGA?
By beta (market sensitivity over 5 years), Dynavax Technologies Corporation (DVAX) is the lower-risk stock at 0.
75β versus SIGA Technologies, Inc. 's 1. 15β — meaning SIGA is approximately 54% more volatile than DVAX relative to the S&P 500. On balance sheet safety, SIGA Technologies, Inc. (SIGA) carries a lower debt/equity ratio of 0% versus 43% for Dynavax Technologies Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — DVAX or SIGA?
By revenue growth (latest reported year), Dynavax Technologies Corporation (DVAX) is pulling ahead at 19.
4% versus -31. 8% for SIGA Technologies, Inc. (SIGA). On earnings-per-share growth, the picture is similar: Dynavax Technologies Corporation grew EPS 503. 2% year-over-year, compared to -60. 2% for SIGA Technologies, Inc.. Over a 3-year CAGR, SIGA leads at -5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DVAX or SIGA?
SIGA Technologies, Inc.
(SIGA) is the more profitable company, earning 24. 6% net margin versus 9. 9% for Dynavax Technologies Corporation — meaning it keeps 24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIGA leads at 25. 1% versus -1. 5% for DVAX. At the gross margin level — before operating expenses — DVAX leads at 82. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DVAX or SIGA more undervalued right now?
On forward earnings alone, SIGA Technologies, Inc.
(SIGA) trades at 2. 8x forward P/E versus 31. 6x for Dynavax Technologies Corporation — 28. 8x cheaper on a one-year earnings basis.
08Which pays a better dividend — DVAX or SIGA?
In this comparison, SIGA (12.
8% yield) pays a dividend. DVAX does not pay a meaningful dividend and should not be held primarily for income.
09Is DVAX or SIGA better for a retirement portfolio?
For long-horizon retirement investors, SIGA Technologies, Inc.
(SIGA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 12. 8% yield, +722. 2% 10Y return). Both have compounded well over 10 years (SIGA: +722. 2%, DVAX: +10. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DVAX and SIGA?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DVAX is a small-cap high-growth stock; SIGA is a small-cap deep-value stock. SIGA pays a dividend while DVAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.